newsfilter
← Latest News
CNBC·

Bristol-Myers to buy heart drugs developer MyoKardia for about $13 billion

U.S. drugmaker Bristol-Myers Squibb said on Monday it would buy heart drugs developer MyoKardia for about $13 billion.